Fentrans 50mcg Transdermal Patch
Prescription Required
Product introduction
Fentrans 50mcg Transdermal Patch is a pain-relieving medicine. It is used to manage persistent, moderate to severe chronic pain that requires continuous, around-the-clock opioid administration for an extended period of time.
Fentrans 50mcg Transdermal Patch is used for the treatment of moderate to severe pain
Fentrans 50mcg Transdermal Patch is used for the treatment of moderate to severe pain
Uses of Fentrans Transdermal Patch
- Severe chronic pain
Benefits of Fentrans Transdermal Patch
In Severe chronic pain
Fentrans 50mcg Transdermal Patch helps to relieve chronic pain in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Applying it will help you go about your daily life more easily. This will help you to go about your daily activities more easily and have a better, more active, quality of life. Consult a doctor if you are not sure.
Side effects of Fentrans Transdermal Patch
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Fentrans
- Abdominal pain
- Dizziness
- Vomiting
- Nausea
- Drowsiness
- Application site redness
- Respiratory depression
- Rigidity
How to use Fentrans Transdermal Patch
Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.
How Fentrans Transdermal Patch works
Fentrans 50mcg Transdermal Patch is an opioid analgesic (pain reliever) that works by blocking the transmission of pain signals to the brain to lower pain perception.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Fentrans 50mcg Transdermal Patch may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Fentrans 50mcg Transdermal Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult a doctor immediately if the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing problems, or limpness.
Consult a doctor immediately if the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing problems, or limpness.
Driving
No interaction found/established
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Fentrans 50mcg Transdermal Patch in patients with kidney disease. Please consult your doctor.
Caution should be excercised in patients with underlying kidney disease.
Caution should be excercised in patients with underlying kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Fentrans 50mcg Transdermal Patch in patients with liver disease. Please consult your doctor.
What if you forget to take Fentrans Transdermal Patch?
If you miss a dose of Fentrans 50mcg Transdermal Patch, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Fentrans 50mcg Transdermal Patch
₹313.0/Transdermal Patch
Fendrop 50mcg Patch
Sun Pharmaceutical Industries Ltd
₹561/transdermal patch
79% costlier
Durogesic 50mcg Patch
Janssen Pharmaceuticals
₹953/transdermal patch
204% costlier
Fact Box
Chemical Class
Phenylpiperidine Derivatives
Habit Forming
Yes
Therapeutic Class
PAIN ANALGESICS
Action Class
Opioids
Patient concerns
FAQs
Is there anything I need to be careful about while on therapy with Fentrans 50mcg Transdermal Patch?
Fentrans 50mcg Transdermal Patch may cause drowsiness and dizziness, especially in the beginning of the treatment. Do not drive or work with tools or machinery if your alertness is affected. It is not advisable to drink alcohol during treatment with this medicine as it might increase sleepiness.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 545-46.
- Yaksh TL, WallaceIn MS. Opioids, Analgesia, and Pain Management. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 505-506.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 539-41.
- Fentanyl. Gloucester Business Park Gloucester: Hameln Pharmaceuticals Ltd.; 10 Jan. 2011 [revised 28 Oct. 2018]. [Accessed 02 Apr. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 02 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:
Marketer details
Name: 6ipain Healthcare Pvt Ltd
Address: 49 KHASRA NO 53/2/1 HASANPUR VILLAGE I.P.EXTN DELHI East Delhi DL 110092 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present